Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
Open accessThe DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.
Abstract
Bacteria can be genetically engineered to kill specific pathogens or inhibit their virulence. We previously developed a synthetic genetic system that allows a laboratory strain of Escherichia coli to sense and kill Pseudomonas aeruginosa in vitro . Here, we generate a modified version of the system, including a gene encoding an anti-biofilm enzyme, and use the probiotic strain Escherichia coli Nissle 1917 as host. The engineered probiotic shows in vivo prophylactic and therapeutic activity against P. aeruginosa during gut infection in two animal models ( Caenorhabditis elegans and mice). These findings support the further development of engineered microorganisms with potential prophylactic and therapeutic activities against gut infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“For example, Hwang et. al. demonstrated that the EcN-based gastrointestinal delivery of anti-biofilm enzyme, dispersin B (DspB), resulted in a reduction of pre-colonized P. aeruginosa abundance in both nematode and murine models29.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [29]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Regulating effector expression in response to bacterial quorum sensing molecules29, pH30, specific carbon sources31–33, temperature34, or combinations of these signals may allow for exquisitely tuned effector functions in various intestinal microenvironments7.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Interdependence of Cell Growth and Gene Expression: Origins and Consequences
Scott, M., Gunderson, C. W., Mateescu, E. M., Zhang, Z., & Hwa, T. (2010) · Science · doi:10.1126/science.1192588 · Cited by 1,470
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Tan, M.-W., Mahajan-Miklos, S., & Ausubel, F. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.715 · Cited by 1,002
Synchronized cycles of bacterial lysis for in vivo delivery
Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., et al. (2016) · Nature · doi:10.1038/nature18930 · Cited by 784
Refinement and standardization of synthetic biological parts and devices
Canton, B., Labno, A., & Endy, D. (2008) · Nature Biotechnology · doi:10.1038/nbt1413 · Cited by 753
The gastrointestinal tract. The “undrained abscess” of multiple organ failure
Marshall, J. C., Christou, N. V., & Meakins, J. L. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00001 · Cited by 707
de Jonge, E., Schultz, M. J., Spanjaard, L., Bossuyt, P. M., Vroom, M. B., Dankert, J., & Kesecioglu, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14409-1 · Cited by 587
Cited by
Items 401–481 of 481
Bakterie Modyfikowane Genetycznie – Perspektywy Zastosowania w Profilaktyce, Diagnostyce I Terapii
Macura, B., Kiecka, A., & Szczepanik, M. (2022) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.2478/am-2022.0003
“Ponadto BMG mogą posiadać zdolność wykrywania patogenów i wydzielania związków, hamujących ich wzrost [1, 18, 30, 55].”
Lactobacillus rhamnosus GG for the prevention of reactive arthritis relapse in children
Chelpachenko, O. E., Danilova, E. I., In, C., Sumenko, V. V., & Ev, I. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-1-196-204
Biological Sensors for Microbiome Diagnostics
Breedon, A. M. E., Beabout, K., Coia, H. G., Davis, C. M., Harbaugh, S. V., Mauzy, C. A., Nelson, M., Saldanha, R., Stamps, B. W., & Goodson, M. S. (2022) · Wiley eBooks · doi:10.1002/9783527825462.ch6
Modulating Residence Time and Biogeography of Engineered Probiotics
Said, R., Mays, Z. J. S., & Nair, N. U. (2022) · Wiley eBooks · doi:10.1002/9783527825462.ch4
Pereira, J. A. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2022.tde-06052022-145847
Engineering Microbes for Smart Diagnostics and Lab-on-Chip
Srijaya, S., Patel, P., Verma, S. K., & Mishra, Y. K. (2022) · Springer eBooks · doi:10.1007/978-981-19-3979-2_5
Exploring the Potential of Microbial Engineering: The Prospect, Promise, and Essence
Patra, S. D., Arunima, A., & Suar, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-3979-2_1
Tchesnokova, V. L., Larson, L., Basova, I., Sledneva, Y., Choudhury, D., Solyanik, T., Heng, J., Bonilla, T. C., Pham, S., Schartz, E. M., et al. (2022) · medRxiv · doi:10.1101/2022.12.16.22283539
“This might be achieved, for example, via the use of probiotic strains, bacteriophages or both [51-54].”
BackgroundSeven reasons for a uveitis specialist to understand the microbiome
Rosenbaum, J. T., Martin, T. M., & Gill, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98338-9.00008-6
Goodson, M. S. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00779
Almkhadhree, E. A. K., Alqaseer, K., & AL-Ruaby, K. J. (2023) · Journal of the Pakistan Medical Association · doi:10.47391/jpma.iq-13
Veteriner Bilimlerinde Probiyotiklerin Terapötik, Profilaktik ve Fonksiyonel Kullanımı
Karadağoğlu, Ö., Rıaz, R., Çıldır, Ö. Ş., Makav, M., Kaya, K., Küçükoflaz, M., AYDIN, E., Ölmez, M., Şahin, T., Sezer, M., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358
Helmint Kaynaklı Enfeksiyonların Kontrolünde Probiyotikler
Aydın, N., Ölmez, N., & Barış, S. A. R. I. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1524
Köpek ve Kedilerde Yeni Gelişmeler: Probiyotikler
Batı, Y. U., Sezer, M., & Akyüz, E. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1523
Obezitede Probiyotiklerin Glukoz ve Lipid Metabolizması Üzerine Etkisi
Aygörmez, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1526
Genetiği Değiştirilmiş Probiyotikler
Çıldır, Ö. Ş. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub358.c1516
Microbial harmony in peril? Identifying the impact of antibiotics on a healthy animal gut
Pal, S. (2023) · Indian Journal of Animal Health · doi:10.36062/ijah.2023.spl.02423
Dey, S., Seyfert, C. E., Fink‐Straube, C., Kany, A. M., Müller, R., & Sankaran, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.13.579303
Daniel, R., Kravchik, V., Huang, R., & Drasinover, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15684-7.00032-4
Microbiome engineering and cancer therapy
Ma, Y., Si, Z., Fang, H., & Chen, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22348-8.00005-2
Emerging Alternative Therapies: Health-Promoting Microbes
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65455-8_1
Designer Probiotics and Postbiotics
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_25
Synthetic Microbes to Modulate the Gut Ecosystem
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_23
Synthetic Biology Toolbox: Developing Microbial Therapeutics
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_22
Genetic Engineering and Genome Editing of Probiotic Microbes
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_24
Preclinical Models for Gastrointestinal Disease and Associated Conditions
Fabris, F. M., Pinto, B. G., Júnior, G. D. F., Melo, R. B., Ferraz, C. P. M., & de Azevedo, O. G. R. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1007515
Zhang, Z., Hu, Y., & Li, J. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.115173
Synthetic Biology and Biofilms
Pakhira, P., Busi, S., & Anupam, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-91863-6_17 · Cited by 1
Biogeochemical Processes and Efficient Utilization of Soil Organic Phosphorus
Zhang, L., Liu, Z., Zhang, W., Feng, X., Tan, W., & Wang, X. (2025) · Frontier studies in soil science · doi:10.1007/978-3-031-91114-9_21
Synthetic biology and genetic engineering in pharmaceutical bioprospecting
Kant, S., Roy, S., & Sarkar, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33032-2.00019-8
Additional file 2 of An engineered genetic circuit for lactose intolerance alleviation
Cheng, M., Cheng, Z., Yu, Y., Liu, W., Li, R., Guo, Z., Qin, J., Zeng, Z., Di, L., Mo, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14913399
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558360
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558342
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558351
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558366
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. Ø., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558336
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558354
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558363
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558348
Additional file 4 of An engineered genetic circuit for lactose intolerance alleviation
Cheng, M., Cheng, Z., Yu, Y., Liu, W., Li, R., Guo, Z., Qin, J., Zeng, Z., Di, L., Mo, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14913405
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558357
Additional file 3 of An engineered genetic circuit for lactose intolerance alleviation
Cheng, M., Cheng, Z., Yu, Y., Liu, W., Li, R., Guo, Z., Qin, J., Zeng, Z., Di, L., Mo, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14913402
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558345
Additional file 5 of An engineered genetic circuit for lactose intolerance alleviation
Cheng, M., Cheng, Z., Yu, Y., Liu, W., Li, R., Guo, Z., Qin, J., Zeng, Z., Di, L., Mo, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14913408
Hof, M. V. ‘., Mohite, O. S., Monk, J. M., Weber, T., Palsson, B. O., & Sommer, M. O. A. (2024) · Figshare · doi:10.6084/m9.figshare.26558339
Advancements in technology for developing recombinant live biotherapeutics
Verma, J. K., & Paul, D. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.01.006 · Cited by 1
Engineering gut–brain therapeutics: Advances in psychobiotics and postbiotic technologies
Theriraja, T. S. H., S, R. K., Ajay, S., Gowri, M., Premajyothi, P. P., Peter, D., Tv, R., Sharma, A., Zohra, B., & Nayik, G. A. (2026) · Food and Humanity · doi:10.1016/j.foohum.2026.101119 · Cited by 2
Shashikanth, M., & Virupakshaiah, D. B. M. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/8187081
Yunda, E. (2019) · theses.fr (ABES) · doi:10.70675/5f5c52bfz73c4z40c0z9c1bz08762366d51e
“utilising cells that provoke infections in human urine tract, lungs, mouth and skin [48], [49], [51], [58]–[65] .”
BackgroundMethodRôle de l'îlot génomique pks dans la synthèse des sidérophores-microcines chez Escherichia coli
Massip, C. (2019) · theses.fr (ABES) · doi:10.70675/79fd3cdcz6be0z491ez95c5zf2b155b65e97
Cherrak, Y. (2020) · theses.fr (ABES) · doi:10.70675/50fe6f7bz2852z46e8z8c69z34c04bfce736
Production of magnetic bacteria and their use in biotechnology
Aubry, M. (2020) · theses.fr (ABES) · doi:10.70675/412befcbz4db8z4b6fz8752z9e544fa75305
Chen, V., Marken, J. P., Murray, R. M., & Cao, M. (2026) · Environmental Microbiology Reports · doi:10.1111/1758-2229.70326
“Engineered EcN have been used in mammalian systems to combat pathogens (Hwang et al. 2017), detect biomarkers for cancer (Danino et al. 2015) and deliver therapeutic payloads (Harimoto et al. 2022) and have even been used in human critical trials to treat metabolic diseases (Kurtz et al. 2019;…”
Lu, Z., Li, J., Hou, S., Zhang, H., & Yan, X. (2026) · Mediators of Inflammation · doi:10.1155/mi/9618148
“For example, MCC950 signi fi cantly reduced IL1 β levels and improved memory de fi cits in an AD mouse model [34].”
Li, Z. Y., Yu, L.-J., Yang, Y.-X., Li, Y., Ata, E. B., Zhou, Y., Zhang, R., Lian, Y.-B., Chen, H., Shi, C., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14051155 · Cited by 1
“The Gram-negative probiotic strain E. coli Nissle 1917 (EcN) was kindly provided by Yong Loo Lin School of Medicine, National University of Singapore (Singapore) [21].”
Zuo, T., Lu, Y., & Li, Y. P. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_37
Cao, J., Li, T., Wang, Y., Xiong, H., Jia, R., Peng, L., Yang, X., Zhong, F., Chen, H., Deng, Q., et al. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c00797
Development strategies for engineered live biotherapeutic products for metabolic diseases
Yun, S., Choi, K.-S., Min, H., Jo, Y. K., & Jang, S. (2026) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2026.2653692 · Cited by 1
“The first system to enhance eLBP functionality through increased genetic circuit complexity involves detecting external stimuli, such as specific molecules or conditions in the host environment, and generating specific responses in vivo [120–122].”
Sequential Plasmid Curing and Genome Editing in Escherichia coli Nissle 1917
Chen, J., Cheng, C., Huang, J., Hong, W., & Zhang, A. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.6c00348
Liu, R., & Wang, J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1797486
“…on validating these approaches in sepsis-specific experimental models and clinical cohorts, identifying optimal patient populations, defining treatment timing, and integrating microbiome profiling with precision medicine strategies (Charbonneau et al., 2020; Hwang et al., 2017; Rouanet et al., 2020).”
Tan, H. Y., Hwang, I. Y., Jayabalan, N., Lee, H. L., Ong, L. J. Y., Lim, C. T., Chang, M. W., & Toh, Y. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71442
Self-citationProbiotics unveiled: bridging general health benefits to the era of precision medicine
Ullah, M., Rizwan, M., Waheed, M. I., Alam, M. S., Jan, S. U., Raza, A., Shahid, M. F., Andoh, V., & Chen, Y. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-05143-1
Influence of probiotics on faecal antibiotic resistome in neonates: a systematic review
Rath, C., Fursule, A., Wong, F., Rao, S. C., & Patole, S. (2026) · Pediatric Research · doi:10.1038/s41390-026-05356-y
Chemo-bio-hybrid probiotic swimmers against Pseudomonas aeruginosa biofilms
Zhang, Y., Chen, F., Xu, M., Feng, S., Song, D., Li, Z., You, X., Lu, X., Pang, J., & Wang, Y. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.180462
Putignani, L., Marsiglia, R., Turco, L., Russo, A., Pane, S., Fusco, A., Lopetuso, L., & Trecarichi, E. M. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1939690
“The same E. coli strain was also engineered to speci fi cally kill pathogens by detecting the autoinducer N-acyl homoserine lactone (AHL) of P. aeruginosa and releasing antibiotics and anti-bio fi lm enzymes (Hwang et al., 2017).”
Zhou, H., He, J., Chen, J., Ge, S., Yü, P., & Zhang, W. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2720162 · Cited by 1
“34 Subsequently, engineered E. coli Nissle was used to metabolize phenylalanine in the setting of phenylketonuria, while ingestible bacterial-electronic systems combined sensor bacteria with electronic readouts for gastrointestinal monitoring.”
Marine Antimicrobial Peptides: A New Wave in the Fight Against ResistancePreprint
Lu, Y., Zhang, H., Wang, Z., Guo, Z., Ge, H., Liu, Y., Liu, X., Ma, H., & Cui, P. (2026) · Qeios · doi:10.32388/6dzq9f
Microbiome and Diseases: Infection
Gerner, R. R., Almási, É. D. H., & Stecher, B. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_14
Engineering oral biomaterials for overcoming gastrointestinal barriers
Chen, Y., Chen, Z., Li, H., Huang, Y., Qu, Y., & Cai, Z. (2026) · Progress in Materials Science · doi:10.1016/j.pmatsci.2026.101842 · Cited by 1
Tavassol, Z. H., Hosseini, F., & Ejtahed, H.-S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29835-6.00007-1
Tang, J., Bai, M., Zubia-Aranburu, J., Zhang, F., Zhang, Q., Tan, Q., Wang, Z., Dong, M., & Liu, L. (2026) · Journal of Microscopy · doi:10.1111/jmi.70182
Evbuomwan, E. M., Khanna, S., Xi, C., Rottinghaus, A. G., Ferreiro, A. L., Kwak, S., Butler, B., Ning, J., Najari, J., Liao, J., et al. (2026) · New Biotechnology · doi:10.1016/j.nbt.2026.09.007
Rathod, B., & Puri, S. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108987
Proteobacteria: A Toolbox for Clinicians
Fusco, W. G., Margarita, E., Capuano, E., Severino, A., Porcari, S., Varca, S., Galasso, T., Lener, E., Gasbarrini, A., & Ianiro, G. (2026) · Microorganisms · doi:10.3390/microorganisms14102238
“Pre-clinical studies show they can reduce the abundance of Proteobacteria and enhance mucosal barrier function while preserving commensal populations [206,207].”
Cheemadan, A., Harnvoravongchai, P., More, S., Kashyap, P., & Scaria, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.07.757339
“Combining intestinal persistence with a pathogen-directed antimicrobial function therefore offers a rationale for developing engineered probiotics for CDI prophylaxis 18 .”
Saini, R., Thakur, B., Мадан, А. К., & Satapathy, M. K. (2026) · Bacteria · doi:10.3390/bacteria5040066
Engineered live biotherapeutic products: design decisions, failure modes, and clinical translation
Shen, S., Zhao, J., & Gao, H. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.2002085
“An engineered EcN strain sensed Pseudomonas aeruginosa and deployed antimicrobial and anti-biofilm functions in nematode and mouse gut-infection models (E1; Hwang et al., 2017).”
Nanomaterials reinforced probiotic delivery: From systematic design to health applications
Zheng, Z., Kan, J., Cui, Z., Meng, J., Wu, Q., Lin, M., Fu, C., Huang, D., Wang, D., Liu, L., et al. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103218
Metadata
- Authors
- Hwang, I. Y., Koh, E., Wong, A., March, J. C., Bentley, W. E., Lee, Y. S., & Chang, M. W.
- Affiliations
- National University of Singapore (SG)
- Cornell University (US)
- University of Maryland, College Park (US)
- Corresponding author
- Chang, Matthew Wook
- ORCID
- Venue
- Nature Communications
- Published
- 2017-04-11
- Volume
- 8
- Issue
- 1
- Pages
- 15028-15028
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5394271
- OpenAlex
- W2605968366
- Cited by
- 472
- References
- 50
- Citations by year
- 2026: 44 · 2025: 53 · 2024: 51 · 2023: 55 · 2022: 68 · 2021: 44 · 2020: 54 · 2019: 53 · 2018: 41 · 2017: 9
- FWCI
- 31.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National University of Singapore (DPRT/943/09/14)
- National University Health System
- Defense Threat Reduction Agency (HDTRA1‐13‐0037, HDTRA1, DPRT/943/09/14)
- U.S. Air Force
- Medical Research Council
- National Medical Research Council (CBRG11nov109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- engineered probiotics, Escherichia coli, Pseudomonas aeruginosa, intestinal infection, Escherichia coli Nissle 1917, prophylaxis, therapeutic activities, Caenorhabditis elegans, mouse model
- MeSH terms
- Microorganisms, Genetically-Modified, Animals, Disease Models, Animal, Escherichia coli, Female, Gastroenteritis, Genetic Engineering, Mice, Inbred ICR, Pseudomonas aeruginosa, Pseudomonas Infections, Virulence, Caenorhabditis elegans, Probiotics, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.